This inventor holds 10 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2018
Title: The Innovative Contributions of Inventor Hongjuan Zhao in Cardiovascular Treatments
Introduction
Hongjuan Zhao is a prominent inventor based in Lexington, MA, USA. With an impressive portfolio of 10 patents, she has made significant strides in the field of cardiovascular treatment. Her recent inventions demonstrate her commitment to developing innovative therapies that have the potential to improve patient outcomes in heart failure.
Latest Patents
Among her notable contributions, Hongjuan has developed novel compositions known as "Synthetic Linear Apelin Mimetics for the Treatment of Heart Failure." This invention focuses on modified apelin-13 peptide sequences designed to treat cardiovascular disease effectively. These compositions exhibit enhanced resistance to degradation and equal or improved bioactivity compared to their wild-type counterparts. The invention outlines both the methods of making these compositions and their applications as pharmaceutically active agents aimed at treating cardiovascular disease.
Another significant invention by Hongjuan is the "Synthetic Apelin Mimetics for the Treatment of Heart Failure," which provides a synthetic polypeptide of Formula I'. These innovations reflect her dedication to advancing therapeutic options for individuals suffering from cardiovascular conditions.
Career Highlights
Hongjuan's career is marked by her association with Novartis AG, a leading global healthcare company focused on reimagining medicine to improve and extend people's lives. Her role there has allowed her to engage in cutting-edge research and development in the pharmaceutical sector, particularly in the area of cardiovascular health.
Collaborations
Throughout her career, Hongjuan has collaborated with esteemed colleagues, including Philipp Grosche and Frederic Zecri. These partnerships have enabled her to combine expertise and resources, further enhancing the quality and impact of her inventions.
Conclusion
In summary, Hongjuan Zhao's innovative contributions to the field of cardiovascular treatments position her as a pivotal figure in medical research. Her inventions, particularly in synthetic apelin mimetics, hold great promise for enhancing the treatment of heart failure and improving patient care. As she continues her work at Novartis AG, her ongoing research will likely lead to further breakthroughs that could benefit countless individuals affected by cardiovascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile